Scholarlink

Background <p>Management of pre-extensively drug-resistant tuberculosis (pre-XDR-TB) during pregnancy poses a formidable clinical challenge, particularly when complicated by tuberculous meningoencephalomyelitis (TBMEM), While the WHO operational handbook provides a general framework for drug-resistant TB, robust evidence and specific guidelines for managing severe CNS involvement in pregnancy remain limited.</p> Case presentation <p>We report the successful outcome for a mother and infant in an extremely high-risk case. The patient, at 17 + 6 weeks of gestation following in vitro fertilization (IVF), was diagnosed with pre-XDR-TB. Hematogenous dissemination was confirmed by chest CT showing diffuse miliary nodules, and spinal MRI confirmed meningoencephalomyelitis. Her clinical course was complicated by life-threatening conditions, including TB-associated sepsis (TB-Sepsis) and severe neurological immune reconstitution inflammatory syndrome (Neuro-IRIS) presenting as an intracranial hypertensive crisis. An individualized, multidisciplinary approach centered on a bedaquiline (Bdq) and delamanid (Dlm)-based regimen was implemented. The patient’s condition was effectively controlled, and she delivered a healthy female infant at 35 + 1 weeks of gestation. Both mother and infant recovered well.</p> Conclusions <p>This case demonstrates that a carefully monitored Bdq/Dlm-based regimen can be a life-saving option for severe DR-TB in pregnancy. It also underscores the critical need for systematic TB screening prior to assisted reproductive technology (ART) in high-burden regions.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Successful treatment of pre-extensively drug-resistant tuberculous meningoencephalomyelitis in pregnancy with a bedaquiline and delamanid-based regimen: a case report

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月30日

查看全文
  • Qi Nie,
  • Yuan Liu,
  • Fan Xiao,
  • Yong Zhou,
  • Tingting Fu,
  • Lijuan Zheng,
  • Dongmei Huang,
  • Qiuping Tang,
  • Ting Liu,
  • Lixuan Tao

摘要

Background

Management of pre-extensively drug-resistant tuberculosis (pre-XDR-TB) during pregnancy poses a formidable clinical challenge, particularly when complicated by tuberculous meningoencephalomyelitis (TBMEM), While the WHO operational handbook provides a general framework for drug-resistant TB, robust evidence and specific guidelines for managing severe CNS involvement in pregnancy remain limited.

Case presentation

We report the successful outcome for a mother and infant in an extremely high-risk case. The patient, at 17 + 6 weeks of gestation following in vitro fertilization (IVF), was diagnosed with pre-XDR-TB. Hematogenous dissemination was confirmed by chest CT showing diffuse miliary nodules, and spinal MRI confirmed meningoencephalomyelitis. Her clinical course was complicated by life-threatening conditions, including TB-associated sepsis (TB-Sepsis) and severe neurological immune reconstitution inflammatory syndrome (Neuro-IRIS) presenting as an intracranial hypertensive crisis. An individualized, multidisciplinary approach centered on a bedaquiline (Bdq) and delamanid (Dlm)-based regimen was implemented. The patient’s condition was effectively controlled, and she delivered a healthy female infant at 35 + 1 weeks of gestation. Both mother and infant recovered well.

Conclusions

This case demonstrates that a carefully monitored Bdq/Dlm-based regimen can be a life-saving option for severe DR-TB in pregnancy. It also underscores the critical need for systematic TB screening prior to assisted reproductive technology (ART) in high-burden regions.